Major basic protein, but not eosinophil cationic protein or eosinophil protein X, is related to atopy in cystic fibrosis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 10, 1999, Pages 1094-1099

  Koller, Dieter Y ^a   Halmerbauer, G ^a   Muller J ^a   Frischer, T ^a   Schierl, M ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Aspergillus fumigatus; Atopy; Cystic fibrosis; Eosinophil; Eosinophil cationic protein; Eosinophil protein X; Major basic protein

Indexed keywords

CELL PROTEIN; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; MAJOR BASIC PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ASPERGILLUS FUMIGATUS; ASTHMA; ATOPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DEGRANULATION; EOSINOPHIL; FEMALE; HUMAN; LUNG INFECTION; LUNG INJURY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SPUTUM ANALYSIS; TISSUE INJURY;

ADOLESCENT; BLOOD PROTEINS; CHILD; CYSTIC FIBROSIS; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RIBONUCLEASES; SPUTUM;

EID: 0032822479     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00127.x     Document Type: Article

References (25)

1. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073 (Erratum, 1437).
2. Berger M. Inflammation in the lung of cystic fibrosis. In: Gershwin E, editor. Clinical reviews in allergy. Vol. 9. New York: Karger, 1987:119-142.
3. Koller DY, Götz M, Eichler I, Urbanek R. Eosinophilic activation in cystic fibrosis. Thorax 1994;49:496-499.
4. Koller DY, Nilsson M, Enander I, Venge P, Eichler I. Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis. Clin Exp Allergy 1998;28:241-248.
5. Koller DY, Götz M, Wojnarowski C, Eichler I. Relationship between disease severity and inflammatory markers in cystic fibrosis. Arch Dis Child 1996;75:498-501.
6. Laufer P, Fink JN, Bruns WT, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 1984;73:44-48.
7. Wojnarowski C, Eichler I, Gartner C, et al. Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. Am J Respir Crit Care Med 1997;155:1902-1907.
8. Koller DY, Herouy Y, Götz M, Hagel E, Urbanek R, Eichler I. Clinical value of monitoring eosinophil activity in asthma. Arch Dis Child 1995;73:413-417.
9. Koller DY, Nothing I, Otto J, Urbanek R, Eichler I. Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity. Am J Respir Crit Care Med 1997;155:1050-1054.
10. Tomassini M, Tsicopoulos A, Tai PC, et al. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. J Allergy Clin Immunol 1991;88:365-375.
11. Shwachman H, Kulczycki L. Long-term study of 105 patients with cystic fibrosis. Am J Dis Child 1958;96:6-15.
12. Koller DY, Urbanek R, Götz M. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am J Respir Crit Care Med 1995;152:629-633.
13. Pizzichini E, Pizzichini M, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid phase measurements. Am J Respir Crit Care Med 1996;154:308-317.
14. Peterson CGB, Enander I, Nystrand J, Anderson AS, Nilsson L, Venge P. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 1991;21:561-567.
15. Wassom DL, Loegering DA, Solley GO, et al. Elevated scrum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest 1981;67:651-661.
16. Wagner JM, Bartemes K, Vernof KK, et al. Analysis of pregnancy-associated major basic protein levels throughout gestation. Placenta 1993;14:671-681.
17. American Thoracic Society. Standardization of spirometry - 1987 update. Am Rev Respir Dis 1987;2:1285-1298.
18. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents. Methods, reference values. Prog Respir Res 1987;22:113-218.
19. Koller DY, Wojnarowski C, Herkner KR, et al. High levels of eosinophil cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol 1997;99:752-756.
20. Schweizer RC, Welmers BA, Raaijmakers JA, Zanen P, Lammers JW, Koendermen L. RANTES and IL-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood 1994;83:3697-3704.
21. Reimert CM, Giwereman B, Hoiby N, Kharazmi A. Eosinophil cationic protein in sputum from cystic fibrosis patients with Pseudomonas aeruginosa infections. Lancet 1994;344:1504-1505.
22. Virchow JC, Hölscher U, Virchow C. Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis 1992;146:604-606.
23. Por PJ, Ackerman SJ, Gleich GJ. Charcot-Leyden crystal protein and eosinophil major basic protein in sputum of patients with respiratory diseases. Am Rev Respir Dis 1984;130:1072-1077.
24. Abu-Ghazaleh RI, Dunette SL, Loegering DA, et al. Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol 1992;52:611-618.
25. Gleich GJ, Leiferman KM. Eosinophils and hypersensitivity diseases. In: Reed CE, editor. Proceedings of the XII International Congress of Allergology and Clinical Immunology. St Louis, MO: CV Mosby, 1986:124-131.